Down syndrome represents one of the most well-established genetic risk factors for early-onset Alzheimer disease (AD), with nearly all individuals developing Alzheimer-related neuropathology by midlife. Despite this predictable biological trajectory, variability in clinical presentation, timing of cognitive decline, and comorbid neurologic conditions continues to pose challenges for clinicians managing this population.

Read it all HERE